Triferic (Rockwell Medical, Inc)
Welcome to the PulseAid listing for the Triferic drug offered from Rockwell Medical, Inc. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rockwell Medical, Inc |
| NON-PROPRIETARY NAME: | FERRIC PYROPHOSPHATE |
| SUBSTANCE NAME: | FERRIC PYROPHOSPHATE CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| ROUTE: | PARENTERAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-02-06 |
| END MARKETING DATE: | 0000-00-00 |
Triferic HUMAN PRESCRIPTION DRUG Details:
| Item Description | Triferic from Rockwell Medical, Inc |
| LABELER NAME: | Rockwell Medical, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5.44(mg/mL) |
| START MARKETING DATE: | 2015-02-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57278-314_5b5dcf9d-071d-6aa4-e053-2991aa0afa32 |
| PRODUCT NDC: | 57278-314 |
| APPLICATION NUMBER: | NDA206317 |
Other FERRIC PYROPHOSPHATE CITRATE Pharmaceutical Manufacturers / Labelers:
